JUN 01, 2021 7:00 AM PDT

Nanoparticles Designed to Enhance Seasonal Flu Vaccines

WRITTEN BY: Tara Fernandez

Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Prevention. New preclinical data from a study published in the Proceedings of the National Academy of Sciences says a novel nanoparticle-based vaccine could help boost the performance and speed up the manufacturing of these seasonal flu vaccines.

"The results are very encouraging," said Jonathan Lovell from the University at Buffalo, senior author of the study.

"Typically, flu vaccines contain either deactivated microbes that cause influenza, or they are based on weakened forms of the disease. The vaccine we're developing is a recombinant protein nanoparticle vaccine that stimulates a strong immune response," Lovell explained.

Among the advantages of the new liposome-based flu vaccine are that it may enhance the effectiveness of seasonal flu shots, and can be produced at mass scales much faster as unlike conventional vaccines, nanoparticle vaccines are not produced in chicken embryos. Additionally, because nanoparticles are so potent, a little goes a long way. Smaller doses are required to protect individuals, which can maximize the supply should the demand spike such as during an influenza pandemic.

From a molecular perspective, viral proteins bound to the surface of liposome nanoparticles enhance the recipient’s immune response to shield against infection. One particular viral protein, called trimeric H3 HA (a type of hemagglutinin), was found to spark a robust immune response in animal studies. However, the liposome system is flexible and modular, allowing for around 10 antigens representing distinct influenza strains to be incorporated into the nanoparticles.

The researchers found that nanoparticle doses as low as 2 nanograms generated a similar level of protection to conventional vaccine formats that require a 1000-fold higher dose. According to the authors, this dose-sparing effect is critical for scaling up the production of vaccines using fewer materials. 

“Taken together, these results show that stable presentation of recombinant HA on immunogenic liposome surfaces in an arrayed fashion enhances functional immune responses and warrants further attention for the development of broadly protective influenza virus vaccines,” wrote the authors.

 


Sources: PNAS, University of Buffalo.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 22, 2021
Immunology
Gene Mutation Keeps Tumors "Cold"
MAR 22, 2021
Gene Mutation Keeps Tumors "Cold"
Immunologists have identified a mechanism through which an oncogene mutation shields pancreatic tumors from immune cells ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
APR 27, 2021
Neuroscience
Leaky Blood-Brain Barrier Linked to Schizophrenia
APR 27, 2021
Leaky Blood-Brain Barrier Linked to Schizophrenia
Researchers from the University of Pennsylvania have found that people with schizophrenia may have a more permeable bloo ...
MAY 20, 2021
Immunology
Why Delaying the 2nd COVID Shot is Paying Off for Some
MAY 20, 2021
Why Delaying the 2nd COVID Shot is Paying Off for Some
A new study indicates that delaying the second “booster” dose of the Pfizer-BioNTech COVID vaccine (to 11-12 ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
Loading Comments...